Ivan Pašić

920 total citations
80 papers, 514 citations indexed

About

Ivan Pašić is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Ivan Pašić has authored 80 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 26 papers in Public Health, Environmental and Occupational Health and 12 papers in Oncology. Recurrent topics in Ivan Pašić's work include Hematopoietic Stem Cell Transplantation (54 papers), Acute Lymphoblastic Leukemia research (25 papers) and Acute Myeloid Leukemia Research (20 papers). Ivan Pašić is often cited by papers focused on Hematopoietic Stem Cell Transplantation (54 papers), Acute Lymphoblastic Leukemia research (25 papers) and Acute Myeloid Leukemia Research (20 papers). Ivan Pašić collaborates with scholars based in Canada, Sweden and Spain. Ivan Pašić's co-authors include Jeffrey H. Lipton, Jonas Mattsson, Rajat Kumar, Arjun Law, Fotios V. Michelis, Auro Viswabandya, Adam D. Durbin, David Malkin, Wilson Lam and Peter N. Ray and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ivan Pašić

67 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivan Pašić Canada	12	238	164	121	107	85	80	514
Geoffroy Venton France	13	191 0.8×	147 0.9×	116 1.0×	69 0.6×	44 0.5×	53	497
Sonia Cellot Canada	14	276 1.2×	410 2.5×	184 1.5×	79 0.7×	83 1.0×	44	787
David Martínez‐Cuadrón Spain	13	325 1.4×	214 1.3×	164 1.4×	34 0.3×	108 1.3×	56	537
Ying‐Wei Lin Japan	11	260 1.1×	270 1.6×	65 0.5×	87 0.8×	71 0.8×	38	515
Hisaki Fujii Japan	15	176 0.7×	143 0.9×	155 1.3×	41 0.4×	114 1.3×	33	580
Junxia Yao China	13	158 0.7×	149 0.9×	144 1.2×	63 0.6×	45 0.5×	46	499
Yu Jing China	15	443 1.9×	301 1.8×	92 0.8×	135 1.3×	102 1.2×	74	667
Toshiaki Ishida Japan	11	63 0.3×	180 1.1×	112 0.9×	84 0.8×	58 0.7×	51	439
Naoko Hosono Japan	14	341 1.4×	317 1.9×	75 0.6×	40 0.4×	47 0.6×	60	646
Miho Nara Japan	12	144 0.6×	276 1.7×	113 0.9×	193 1.8×	19 0.2×	31	613

Countries citing papers authored by Ivan Pašić

Since Specialization

Citations

This map shows the geographic impact of Ivan Pašić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Pašić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Pašić more than expected).

Fields of papers citing papers by Ivan Pašić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Pašić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Pašić. The network helps show where Ivan Pašić may publish in the future.

Co-authorship network of co-authors of Ivan Pašić

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Pašić. A scholar is included among the top collaborators of Ivan Pašić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Pašić. Ivan Pašić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Carol, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms. European Journal Of Haematology. 115(2). 142–152. 3 indexed citations

Law, Arjun, Wilson Lam, Mats Remberger, et al.. (2025). Impact of graft‐versus‐host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology. 207(3). 938–945. 1 indexed citations

Remberger, Mats, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia. Transplantation and Cellular Therapy. 31(11). 916.e1–916.e11. 1 indexed citations

Jamani, Kareem, Mohamed Elemary, Ivan Pašić, et al.. (2025). Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival. Annals of Hematology. 104(10). 5403–5413.

Remberger, Mats, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation. Cancers. 17(4). 651–651.

Chen, Carol, Eshetu G. Atenafu, Arjun Law, et al.. (2025). Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure. Transplantation and Cellular Therapy. 31(10). 810–819. 1 indexed citations

Law, Arjun, Igor Novitzky‐Basso, Ivan Pašić, et al.. (2025). A decade of experience using ATG and PTCy for graft‐versus‐host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation. British Journal of Haematology. 207(5). 2049–2058.

Pašić, Ivan, Mats Remberger, Carol Chen, et al.. (2024). Treosulfan- Versus Busulfan-based Conditioning in Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Single-center Retrospective Propensity Score-matched Cohort Study. Transplantation and Cellular Therapy. 30(7). 681.e1–681.e11. 2 indexed citations

Pašić, Ivan, Arjun Law, Wilson Lam, et al.. (2024). Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience. European Journal Of Haematology. 113(4). 477–484. 3 indexed citations

10.

Remberger, Mats, Carol Chen, Igor Novitzky‐Basso, et al.. (2024). PTCy-based graft-versus-host disease prophylaxis for matched sibling donor allogeneic hematopoietic cell transplantation. Blood Advances. 9(3). 660–669. 7 indexed citations

11.

Grewal, Keerat, et al.. (2023). Syndrome de lyse tumorale. Canadian Medical Association Journal. 195(28). E969–E970. 1 indexed citations

12.

Novitzky‐Basso, Igor, Christopher J. Patriquin, Ivan Pašić, et al.. (2023). Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD. Transplantation and Cellular Therapy. 29(12). 773.e1–773.e10. 3 indexed citations

13.

Pašić, Ivan, Ram Vasudevan Nampoothiri, Ioannis Prassas, et al.. (2023). Multiplex proteomics using proximity extension assay for the identification of protein biomarkers predictive of acute graft-vs.-host disease in allogeneic hematopoietic cell transplantation. Clinical Chemistry and Laboratory Medicine (CCLM). 61(6). 1005–1014.

14.

Mittal, Ankit, Victor H. Ferreira, Sagar Kothari, et al.. (2023). Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 29(11). 706.e1–706.e7. 5 indexed citations

15.

Novitzky‐Basso, Igor, Ivan Pašić, Wilson Lam, et al.. (2023). A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes. Hematology/Oncology and Stem Cell Therapy. 17(1). 60–71. 2 indexed citations

16.

Kimura, Muneyoshi, Victor H. Ferreira, Sagar Kothari, et al.. (2022). Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 28(10). 706.e1–706.e10. 22 indexed citations

17.

Kitchlu, Abhijat, et al.. (2022). Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes. Bone Marrow Transplantation. 57(9). 1411–1420. 8 indexed citations

18.

Lee, Katherine J., Shiyi Chen, Arjun Law, et al.. (2021). Weight Loss after Allogeneic Stem Cell Transplantation Is Associated with Increased Mortality. Transplantation and Cellular Therapy. 27(3). S181–S182. 1 indexed citations

19.

Lipton, Jeffrey H., Dennis Dong Hwan Kim, Auro Viswabandya, et al.. (2021). Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients. Clinical Lymphoma Myeloma & Leukemia. 22(5). e327–e334. 4 indexed citations

20.

Pašić, Ivan, Adam Shlien, Adam D. Durbin, et al.. (2010). Recurrent Focal Copy-Number Changes and Loss of Heterozygosity Implicate Two Noncoding RNAs and One Tumor Suppressor Gene at Chromosome 3q13.31 in Osteosarcoma. Cancer Research. 70(1). 160–171. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact